AXSOME THERAPEUTICS INC's ticker is AXSM and the CUSIP is 05464T104. A total of 188 filers reported holding AXSOME THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is 3.71 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $64,019 | -2.7% | 916 | 0.0% | 0.00% | – |
Q2 2023 | $65,824 | +128966.7% | 916 | +10.9% | 0.00% | – |
Q1 2023 | $51 | -20.3% | 826 | 0.0% | 0.00% | -100.0% |
Q4 2022 | $64 | -99.8% | 826 | 0.0% | 0.00% | – |
Q3 2022 | $37,000 | +8.8% | 826 | -7.0% | 0.00% | – |
Q2 2022 | $34,000 | +183.3% | 888 | +208.3% | 0.00% | – |
Q1 2022 | $12,000 | -78.9% | 288 | -86.1% | 0.00% | – |
Q4 2021 | $57,000 | +256.2% | 2,078 | +324.1% | 0.00% | – |
Q3 2021 | $16,000 | -91.1% | 490 | -81.7% | 0.00% | -100.0% |
Q2 2021 | $180,000 | +9.1% | 2,671 | -8.6% | 0.00% | 0.0% |
Q1 2021 | $165,000 | -30.7% | 2,921 | 0.0% | 0.00% | -50.0% |
Q4 2020 | $238,000 | +95.1% | 2,921 | +70.3% | 0.00% | +100.0% |
Q3 2020 | $122,000 | -41.1% | 1,715 | -31.7% | 0.00% | -50.0% |
Q2 2020 | $207,000 | +1492.3% | 2,512 | +1041.8% | 0.00% | – |
Q1 2020 | $13,000 | -58.1% | 220 | -26.7% | 0.00% | – |
Q4 2019 | $31,000 | +416.7% | 300 | 0.0% | 0.00% | – |
Q3 2019 | $6,000 | – | 300 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ALETHEA CAPITAL MANAGEMENT, LLC | 1,009,799 | $82,268,000 | 41.24% |
Fairmount Funds Management LLC | 220,098 | $17,931,000 | 6.41% |
WMS Partners, LLC | 250,000 | $20,368,000 | 3.51% |
IRIDIAN ASSET MANAGEMENT LLC/CT | 2,064,158 | $168,167,000 | 3.06% |
MORGAN JESS S & CO INC | 44,468 | $3,623,000 | 2.88% |
RTW INVESTMENTS, LP | 1,672,416 | $136,252,000 | 2.29% |
RA Capital Management | 1,655,447 | $134,869,000 | 1.88% |
Nicholas Investment Partners, LP | 207,452 | $16,901,000 | 1.30% |
Affinity Asset Advisors, LLC | 25,000 | $2,037,000 | 1.08% |
Parkman Healthcare Partners LLC | 30,758 | $2,506,000 | 0.64% |